Elder Care (Everybody)

A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments.

Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes that spread unevenly across the brain and extend beyond amyloid plaques. Key memory regions showed major shifts in cholesterol and energy-related molecules. The findings hint that Alzheimer’s is a whole-brain metabolic disruption—not just a protein problem.

Heart disease is on track to tighten its grip on American women. New projections from the American Heart Association warn that over the next 25 years, cardiovascular disease will rise sharply, driven largely by a surge in high blood pressure, diabetes, and obesity. By 2050, nearly 60% of women in the U.S. could have high blood pressure, and close to one in three women ages 22 to 44 may already be living with some form of heart disease.

A sweeping new analysis of the evidence suggests that exercise therapy — long promoted as a first-line treatment for osteoarthritis — may offer only small and short-lived relief, and in some cases might be no better than doing nothing at all. After reviewing dozens of clinical trials involving more than 13,000 participants, researchers found that benefits for knee osteoarthritis pain were minimal and tended to shrink in larger or longer-term studies.

Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer’s, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain’s vascular health, not just its plaques.

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care.

Chronic wounds often spiral out of control because oxygen can’t reach the deepest layers of injured tissue. A new gel developed at UC Riverside delivers a continuous flow of oxygen right where it’s needed most, using a tiny battery-powered system. In high-risk mice, wounds healed in weeks instead of worsening. The innovation could dramatically reduce amputations—and may even open doors for lab-grown organs.

A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline.

Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies.

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace what’s been lost.

Breathing polluted air may do more than harm your lungs — it could also increase your risk of Alzheimer’s disease. In a sweeping study of nearly 28 million older Americans, researchers found that long term exposure to fine particle air pollution was linked to a higher likelihood of developing Alzheimer’s. The connection appeared to stem largely from pollution’s direct effects on the brain, rather than through related health conditions like hypertension or depression.

A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and other inflammation-related conditions.

A newly discovered bacterial duo may be the hidden cause of chronic constipation. The two microbes break down the colon’s protective mucus layer, leaving stool dry and hard — a problem traditional laxatives don’t fix. Parkinson’s patients, who often struggle with constipation years before tremors appear, have higher levels of these bacteria. Blocking the bacteria’s mucus-destroying enzyme prevented constipation in mice, hinting at a new treatment strategy.

A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing.

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.